AzTrials
AzTrials

Hospital ReadmissionNCT04422041

Comparison of Early Versus Very Early Postnatal Discharge on Hospital Readmissions in Newborns

A study testing Time to discharge less than 24 hours and Discharge time between 24 and 48 hours in people with Hospital Readmission and Newborn Morbidity, run by Universidad Autonoma de Nuevo Leon.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study compared hospital readmission and complications between very early discharge and early discharge in healthy newborn patients. Read more about this study

Who is it for?
Ages 1 minute to 2 days
What is being tested?
Time to discharge less than 24 hours and Discharge time between 24 and 48 hours
Could I receive a placebo?
No, everyone receives an active treatment
How many people
354 participants
Where
No sites listed yet
Study dates
1 Jul 2016to 29 Jul 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 minute to 2 days
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Healthy newborns that were born from vaginal delivery in primiparous or multiparous women where both the mother and the newborn were deemed as eligible for early discharge according to the American Association of Pediatrics criteria and by a clinical obstetric mother evaluation.

Who cannot join

  • Placenta praevia, abnormal bleeding during vaginal delivery (considered as greater than 500mL), inhability to deambulate, medical complications from previous a previous pregnancy, 3rd or 4th degree perineal laceration as well as medical conditions that required any monitorization for more than 24 hours after delivery.

About this study

Official title: Comparison of Early Versus Very Early Postnatal Discharge on Hospital Readmissions in Newborns: A Prospective Study

This study compared hospital readmission and complications between very early discharge and early discharge in healthy newborn patients.

Read the detailed description

Introduction. Very early postnatal discharge is defined as a hospital stay of the mother-child dyad of less than 24 hours. It is usually performed in public institutions of low-income countries due to high birth rates; it has not been associated to a higher proportion of neonatal admissions, however, very early discharge might increase this risk. The objective of this study was to compare the rate hospital readmission in patients with very early vs early postnatal discharge.

Methods A prospective, randomized clinical study was performed with healthy term infants born in a hospital in Mexico from July 2016 to June 2018. Sample was randomized into two groups, a very early discharge group (<24 hours) and an early discharge group (24-48 hours). Hospital readmission rate was analyzed in both groups.

Being tested
Time to discharge less than 24 hours, Discharge time between 24 and 48 hours
Keywords
Newborn Infant, Hospital readmission, Early discharge, Very early discharge

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Time to discharge less than 24 hoursOther

    Allow the joint medical discharge of the newborn together with its mother in less than 24 hours after birth in a healthy patient, without obstetric complications and who does not present comorbidities and complications.

  • Discharge time between 24 and 48 hoursOther

    Allow the joint medical discharge of the newborn together with its mother between 24-48 hours after birth in a healthy patient, without obstetric complications and who does not present comorbidities and complications.

Study groups in NCT04422041
Study groupRoleWhat they receive
Early dischargeActive comparatorDischarge between 24 and 48 hours
Receives: Other: Discharge time between 24 and 48 hours
Very early dischargeExperimentalDischarge in less than 24 hours
Receives: Other: Time to discharge less than 24 hours

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hospital readmission rate

    Proportion of participant newborns who were readmitted into the hospital during follow up

    Measured: 28 days

Secondary outcomes (2)
  1. Rate of attention in emergency services

    Proportion of participant newborns who attended the emergency services during follow up

    Measured: 28 days

  2. Readmission rate associated factors

    Statistical associations between the primary outcome and other variables of interest

    Measured: 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jun 2020
  2. Study start1 Jul 2016
  3. Primary completion29 Jun 2018
  4. Study completion29 Jul 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
They were selected based on a random computer program in a 1: 1 model, assigning each subject randomly to one of the two study groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
354 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04422041
Sponsor's protocol ID
PE15-039
Status last verified
Jun 2020
First submitted
4 Jun 2020
Last updated
9 Jun 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Jones E, Taylor B, MacArthur C, Pritchett R, Cummins C. The effect of early postnatal discharge from hospital for women and infants: a systematic review protocol. Syst Rev. 2016 Feb 8;5:24. doi: 10.1186/s13643-016-0193-9.

    PubMed 26857705
  • Brown S, Small R, Faber B, Krastev A, Davis P. Early postnatal discharge from hospital for healthy mothers and term infants. Cochrane Database Syst Rev. 2002;(3):CD002958. doi: 10.1002/14651858.CD002958.

    PubMed 12137666
  • Benitz WE; Committee on Fetus and Newborn, American Academy of Pediatrics. Hospital stay for healthy term newborn infants. Pediatrics. 2015 May;135(5):948-53. doi: 10.1542/peds.2015-0699.

    PubMed 25917993
  • Chalmers B, Mangiaterra V, Porter R. WHO principles of perinatal care: the essential antenatal, perinatal, and postpartum care course. Birth. 2001 Sep;28(3):202-7. doi: 10.1046/j.1523-536x.2001.00202.x.

    PubMed 11552969
  • Capurro H, Konichezky S, Fonseca D, Caldeyro-Barcia R. A simplified method for diagnosis of gestational age in the newborn infant. J Pediatr. 1978 Jul;93(1):120-2. doi: 10.1016/s0022-3476(78)80621-0. No abstract available.

    PubMed 650322
  • SILVERMAN WA, ANDERSEN DH. A controlled clinical trial of effects of water mist on obstructive respiratory signs, death rate and necropsy findings among premature infants. Pediatrics. 1956 Jan;17(1):1-10. No abstract available.

    PubMed 13353856

Questions about this trial

What is this clinical trial studying?

A study testing Time to discharge less than 24 hours and Discharge time between 24 and 48 hours in people with Hospital Readmission and Newborn Morbidity, run by Universidad Autonoma de Nuevo Leon.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hospital readmission rate (time frame: 28 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04422041, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in